spalei@chem.iitkgp.ac.in
Dr. Shubhendu Palei Assistant Professor & Ramalingaswami Fellow Room HP-204, High Pressure Building Department of Chemistry Indian Institute of Technology (IIT) Kharagpur Kharagpur-721302 West Bengal, India
<ul>
<li><strong>Ph.D in Chemical Biology</strong>, University of Muenster, Germany<strong> </strong>(magna cum laude plus) (<strong>10/2012 – 08/2017</strong>)</li>
<li><strong>M.Sc in Chemistry</strong>, IIT Kanpur, India (<strong>07/2010 – 06/2012</strong>)</li>
<li><strong>Integrated B.Sc B.Ed </strong>(4 year), Regional Institute of Education (RIE) (Affiliated to NCERT, New Delhi), Utkal University, Bhubaneswar (<strong>07/2006 – 06/2010</strong>)</li>
<li><strong>+2 Science</strong>, Council of Higher Secondary Education (CHSE), Odisha (<strong>2003 - 2005</strong>)</li>
<li> <strong>10th</strong>, Board of Secondary Education, Odisha (<strong>2003</strong>)</li>
</ul>
<ul>
<li><strong>Assistant Professor </strong>(Grade-I), Indian Institute of Technology (IIT) Kharagpur (<strong>04/2024 </strong><strong>– present</strong>)</li>
<li><strong>Senior Scientist</strong>, <a href="https://www.athebio.com/">Athebio AG</a> (Biotech Start-up Company), Zurich, Switzerland<strong> </strong>(<strong>01/2023 – 10/2023</strong>)</li>
<li><strong>Post-doctoral researcher </strong>(Chemical Biology and Genetic code expansion), Department of Chemistry and Applied Biosciences (D-CHAB), ETH Zürich, Switzerland<strong> </strong>(<strong>10/2021 – 12/2022</strong>)<em> Supervisor: <a href="https://lang.ethz.ch/">Prof. Dr. Kathrin Lang</a></em></li>
<li><strong>Post-doctoral researcher </strong>(Epigenetics Chemical Biology of TET enzymes)<strong>, </strong>Chemistry and Chemical Biology (CCB), TU Dortmund, Germany (<strong>01/2018 – 05/2021</strong>) <em>Supervisor: <a href="https://ccb.tu-dortmund.de/en/professorships/cb/summerer/">Prof. Dr. Daniel Summerer</a></em></li>
<li><strong>Bridging Post-doc </strong>(Cyclic peptides, Bacterial display, Inteins), Institute of Biochemistry, University of Muenster, Germany (<strong>09/2017 – 12/2017</strong>) <em>Supervisor: <a href="https://www.uni-muenster.de/Chemie.bc/en/forschung/mootz/index.html">Prof. Dr. Henning. D. Mootz</a></em></li>
<li><strong>Ph.D. in Chemical Biology </strong>(Cyclic peptides, Bacterial display, Inteins)<strong>, </strong>Institute of Biochemistry, University of Muenster, Germany (<strong>10/2012 – 08/2017</strong>) <em>Supervisor: <a href="https://www.uni-muenster.de/Chemie.bc/en/forschung/mootz/index.html">Prof. Dr. Henning. D. Mootz</a></em>.</li>
<li><strong>MSc Dissertation </strong>(Amyloid peptide aggregation), Department of Chemistry & Department of Bioscience and Bioengineering, IIT Kanpur, India (<strong>12/2011– 04/2012</strong>) <strong> <em> </em></strong><em>Supervisor: <a href="https://home.iitk.ac.in/~sverma/index.html">Prof. Dr. Sandeep Verma</a> (Dept. of Chemistry)<strong>,</strong></em> <em>Co-supervisor: <a href="https://www.iitk.ac.in/bsbe/ashwani-kumar-thakur">Prof. Dr. Ashwani Kumar<strong> </strong>Thakur</a><strong> </strong>(Dept. of Biological Science and Bioengineering)</em></li>
</ul>
Our research focuses on developing chemical and synthetic biology tools for molecular level understanding of the histone code with implications in fundamental science and drug discovery. My group will develop cyclic peptide-based ligands to modulate specific epigenetic PTM states of histones both in vitro and in vivo. We aim to mimic the epigenetic modifications of histones e.g. methylation, acetylation, ubiquitination using genetic code expansion technique to understand the molecular basis of crosstalks and their roles in controlling the chromatin landscape. We aim to rescue the loss-of-function effect of oncohistone mutations by site specifically introducing specific PTM by genetic code expansion. We want to incorporate photocrosslinker AA in histones to study PTM readers and erasers.
<p>Our research focuses on developing chemical and synthetic biology tools for molecular level understanding of the histone code with implications in fundamental science and drug discovery. My group will develop cyclic peptide-based ligands to modulate specific epigenetic PTM states of histones both in vitro and in vivo. We aim to mimic the epigenetic modifications of histones e.g. methylation, acetylation, ubiquitination using genetic code expansion technique to understand the molecular basis of crosstalks and their roles in controlling the chromatin landscape. We aim to rescue the loss-of-function effect of oncohistone mutations by site specifically introducing specific PTM by genetic code expansion. We want to incorporate photocrosslinker AA in histones to study PTM readers and erasers.</p>
No patents on record.